Skip to main content
. 2021 Nov 29;27:e934436-1–e934436-10. doi: 10.12659/MSM.934436

Table 4.

The survival analysis based on relative reasons of death between groups.

Reasons of death TIPS+TACE (n=42) Endoscopy+TACE (n=38)
Liver failure 19 (45.24%) 17 (44.74%)
Gastrointestinal rebleeding 1 (2.38%) 4 (10.53%)
Hepatic encephalopathy 2 (4.76%) 3 (7.89%)
Multiple organ failure 1 (2.38%) 0 (0.00%)
Uncontrollable infection 2 (4.76%) 2 (5.26%)
Uncontrollable intrahepatic tumor progression 10 (23.81%) 8 (21.05%)
Uncontrolled progression of extrahepatic metastases 7 (16.67%) 4 (10.53%)

TIPS – transjugular intrahepatic portosystemic shunt; TACE – transarterial chemoembolization. Results reported as N (%) unless otherwise indicated.